Dr. Anam Khan, MD

Dr. Khan practices at The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.

Dr. Khan's NPI, 1083053466, was assigned on June 19, 2013. Dr. Khan graduated from Aga Khan Medical College in 2010. Dr. Khan holds Texas license S0476.

Dr. Khan's primary practice is The University of Texas MD Anderson Cancer Center, at 1515 Holcombe Blvd, Houston, TX 77030.

Dr. Khan's primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System. The medical group on file is Physicians Referral Service.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Khan practices. Vendor and product names are available with a free account.

Gastroenterology is Dr. Khan's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Khan is board certified in gastroenterology by the American Board of Internal Medicine. Dr. Khan is licensed in Texas.

Dmand AI lists acid reflux, acute gastroduodenitis, colonoscopy, gastroduodenitis, gastroenteritis, gastrointestinal bleeding, hemorrhoids and intestinal diverticulosis among the conditions Dr. Khan treats.

CMS data shows 402 Medicare services from Dr. Khan across 9 procedure codes in 2024, for 299 Medicare patients. Medicare paid $38,464 for them.

CMS counts 299 Medicare patients who saw Dr. Khan in 2024. The largest group is 65 to 74, with 157 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 6% are also on Medicaid. Their average risk score is 2.33, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Khan's median patient age at 66, with 55% women.

In 2024, Dr. Khan wrote 103 Medicare Part D claims for 30 patients. 71% of them were for generic drugs. CMS names the drug for 35 of them, across 3 drugs with 11 or more claims each, at $1,212 in total drug cost. In 2023, CMS named 36 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Khan for performance year 2024, reported as part of a group. Dr. Khan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Khan as offering telehealth. CMS counts 77 procedures of colonoscopy by Dr. Khan, more than 73% of the clinicians it reports for that procedure.

Dmand AI links 31 papers to Dr. Khan, published from 2012 to 2024. 2021 was the busiest year, with 4. The most frequent topics are Rats, Wistar, Brain and Dacarbazine. Dr. Khan has published most often in Am J Gastroenterol. Dr. Khan's most frequent co-authors are Hashem Beshir El-Serag, MD, MPH, Suresh T. Chari, MD and Waleed Tallat Kayani, MD.

CMS Open Payments shows 4 general payments to Dr. Khan from 3 drug and device companies from 2020 to 2025. Food and beverage make up the largest share, 100% of the total. Olympus America Inc. paid the most, $37.

Dr. Khan graduated from Aga Khan Medical College in 2010.

Dr. Khan is in network with 3 carriers, including Aetna, Blue Cross Blue Shield of Michigan and CMS Medicare. HMO plans come from the most carriers, 2. Check the plan with the practice before a visit.